{
  "ticker": "IVX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02960886",
  "id": "02960886",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250623",
  "time": "0941",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250623/pdf/06l03xb7mcvybt.pdf",
  "summary": "**Capital Raising Announcement:**  \n- **Structure:** Fully underwritten non-renounceable Loyalty Option Entitlement Offer.  \n- **Capital Raised:** Up to ~$1 million (initial Loyalty Options) and ~$16 million (if all options exercised).  \n- **Key Dates:**  \n  - Ex-date: 25 June 2025  \n  - Record date: 26 June 2025  \n  - Offer closes: 10 July 2025  \n- **Terms:**  \n  - 77 Loyalty Options per 100 shares at $0.015 each.  \n  - Exercise price: $0.14; expiry 30 June 2027.  \n  - Piggy-Back Options (1:2 ratio) if exercised by 31 Dec 2025 (exercise price $0.21).  \n- **Use of Proceeds:** Funding clinical trials (skin cancer, anogenital cancer), working capital.  \n- **Underwriting:** Fully underwritten by Blue Ocean Equities; CEO sub-underwrites $150k.  \n\n**Other Material Info:** Ineligible shareholders (e.g., US-based) excluded from participation.",
  "usage": {
    "prompt_tokens": 3138,
    "completion_tokens": 241,
    "total_tokens": 3379,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-22T23:58:54.351967"
}